Hengehold Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.1M | Buy |
47,453
+1,590
| +3% | +$186K | 0.47% | 45 |
|
|
2026
Q1 | $5.52M | Sell |
45,863
-291
| -0.6% | -$33.6K | 0.48% | 45 |
|
|
2025
Q4 | $4.86M | Buy |
46,154
+302
| +0.7% | +$28.3K | 0.41% | 50 |
|
|
2025
Q3 | $3.85M | Buy |
45,852
+2,196
| +5% | +$181K | 0.33% | 60 |
|
|
2025
Q2 | $3.46M | Buy |
43,656
+1,313
| +3% | +$104K | 0.32% | 62 |
|
|
2025
Q1 | $3.8M | Buy |
42,343
+2,354
| +6% | +$220K | 0.36% | 54 |
|
|
2024
Q4 | $3.98M | Buy |
39,989
+112
| +0.3% | +$11.5K | 0.37% | 51 |
|
|
2024
Q3 | $4.53M | Buy |
39,877
+1,045
| +3% | +$124K | 0.43% | 47 |
|
|
2024
Q2 | $4.81M | Buy |
38,832
+70
| +0.2% | +$9.02K | 0.5% | 41 |
|
|
2024
Q1 | $5.11M | Sell |
38,762
-907
| -2% | -$112K | 0.55% | 37 |
|
|
2023
Q4 | $4.32M | Sell |
39,669
-411
| -1% | -$42.7K | 0.51% | 39 |
|
|
2023
Q3 | $4.13M | Sell |
40,080
-500
| -1% | -$53.9K | 0.54% | 37 |
|
|
2023
Q2 | $4.68M | Sell |
40,580
-520
| -1% | -$59K | 0.62% | 33 |
|
|
2023
Q1 | $4.37M | Sell |
41,100
-1,237
| -3% | -$134K | 0.6% | 35 |
|
|
2022
Q4 | $4.7M | Sell |
42,337
-344
| -0.8% | -$35.2K | 0.65% | 35 |
|
|
2022
Q3 | $3.68M | Buy |
42,681
+123
| +0.3% | +$11K | 0.57% | 32 |
|
|
2022
Q2 | $3.88M | Buy |
42,558
+490
| +1% | +$43.4K | 0.55% | 31 |
|
|
2022
Q1 | $3.45M | Buy |
42,068
+2,976
| +8% | +$235K | 0.47% | 37 |
|
|
2021
Q4 | $3M | Buy |
39,092
+631
| +2% | +$50.3K | 0.37% | 39 |
|
|
2021
Q3 | $2.89M | Buy |
38,461
+798
| +2% | +$60.7K | 0.38% | 39 |
|
|
2021
Q2 | $2.93M | Buy |
37,663
+47
| +0.1% | +$3.5K | 0.38% | 39 |
|
|
2021
Q1 | $2.77M | Buy |
37,616
+1,027
| +3% | +$75.8K | 0.38% | 41 |
|
|
2020
Q4 | $2.86M | Buy |
36,589
+414
| +1% | +$31.7K | 0.43% | 32 |
|
|
2020
Q3 | $2.86M | Sell |
36,175
-1,576
| -4% | -$123K | 0.46% | 28 |
|
|
2020
Q2 | $2.79M | Sell |
37,751
-1,147
| -3% | -$86.3K | 0.49% | 25 |
|
|
2020
Q1 | $2.86M | Sell |
38,898
-446
| -1% | -$35.1K | 0.61% | 23 |
|
|
2019
Q4 | $3.41M | Buy |
39,344
+144
| +0.4% | +$11.8K | 0.58% | 23 |
|
|
2019
Q3 | $3.15M | Sell |
39,200
-1,000
| -2% | -$80.1K | 0.58% | 22 |
|
|
2019
Q2 | $3.22M | Sell |
40,200
-1,029
| -2% | -$78.8K | 0.62% | 26 |
|
|
2019
Q1 | $3.27M | Sell |
41,229
-1,118
| -3% | -$83.6K | 0.77% | 25 |
|
|
2018
Q4 | $3.09M | Sell |
42,347
-2,787
| -6% | -$197K | 0.99% | 21 |
|
|
2018
Q3 | $3.06M | Sell |
45,134
-1,990
| -4% | -$127K | 0.77% | 23 |
|
|
2018
Q2 | $2.73M | Buy |
47,124
+9,475
| +25% | +$535K | 0.71% | 27 |
|
|
2018
Q1 | $1.96M | Buy |
37,649
+1,440
| +4% | +$77.8K | 0.51% | 44 |
|
|
2017
Q4 | $1.94M | Buy |
36,209
+1,443
| +4% | +$80K | 0.51% | 46 |
|
|
2017
Q3 | $2.12M | Buy |
34,766
+513
| +1% | +$31.1K | 0.56% | 40 |
|
|
2017
Q2 | $2.1M | Buy |
34,253
+1,894
| +6% | +$115K | 0.59% | 37 |
|
|
2017
Q1 | $1.96M | Buy |
32,359
+891
| +3% | +$54.1K | 0.54% | 43 |
|
|
2016
Q4 | $1.77M | Buy |
31,468
+930
| +3% | +$54.4K | 0.54% | 45 |
|
|
2016
Q3 | $1.82M | Sell |
30,538
-276
| -0.9% | -$16.1K | 0.58% | 35 |
|
|
2016
Q2 | $1.69M | Buy |
30,814
+17
| +0.1% | +$905 | 0.55% | 42 |
|
|
2016
Q1 | $1.55M | Buy |
30,797
+409
| +1% | +$20K | 0.5% | 47 |
|
|
2015
Q4 | $1.53M | Buy |
30,388
+860
| +3% | +$43.4K | 0.55% | 45 |
|
|
2015
Q3 | $1.39M | Buy |
29,528
+226
| +0.8% | +$12K | 0.6% | 43 |
|
|
2015
Q2 | $1.59M | Buy |
29,302
+433
| +1% | +$24.3K | 0.57% | 41 |
|
|
2015
Q1 | $1.58M | Buy |
28,869
+585
| +2% | +$33.1K | 0.55% | 43 |
|
|
2014
Q4 | $1.53M | Buy |
+28,284
| New | +$1.58M | 0.54% | 42 |
|
Other funds holding MRK
ECSS
Hengehold Capital Management's MRK Position: Q2 2026 in Review
Hengehold Capital Management increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $186K and bringing the position to 47,453 shares worth $6.1M. The position accounts for 0.47% of the portfolio, ranked #45.
Hengehold Capital Management first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Hengehold Capital Management held 47,453 shares of Merck worth $6.1M as of Q2 2026.
- Hengehold Capital Management bought 1,590 Merck shares in Q2 2026, an estimated $186K.
- Merck made up 0.47% of Hengehold Capital Management's portfolio in Q2 2026, its #45 holding.
- Hengehold Capital Management first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.